Charles J. Link, Jr, MD
Charles J. Link Jr, MD, co-founded NewLink Genetics in 1999 with the idea of leveraging the body's immune system to fight cancer. He is chief executive officer, chief scientific officer, and chairman of the Board of Directors. Dr Link was appointed by United States Senator John Glenn of Ohio to the United States Air Force Academy where he studied chemistry. Prior to graduating, he was accepted to a special program at Stanford University School of Medicine in Stanford, California, where he received his bachelor's degree in chemistry and his medical degree. Dr Link interned at the University of California, San Francisco, and completed his residency and fellowship training in medical oncology at the National Cancer Institute in Bethesda, Maryland, where he also served as an attending physician. Dr Link practiced oncology for 18 years, most recently caring for patients part-time at Medical Oncology and Hematology Associates of Iowa from 1995 to 2013. He also served as director of the Human Gene Therapy Research Institute, which is part of the John Stoddard Cancer Center at Iowa Methodist Medical Center. In addition to spending time with his family, Dr Link enjoys exercising and pouring over scientific journals.